Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial aging and dysfunction in Alzheimer's disease.

Patrick G Sullivan1, Maile R Brown

  • 1University of Kentucky, Spinal Cord and Brain Injury Research Center (SCoBIRC), Lexington, KY 40536-0305, USA. PatSull@uky.edu

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|March 30, 2005
PubMed
Summary

Alzheimer's disease (AD) involves disruptions in brain energy metabolism and mitochondrial dysfunction. These metabolic changes occur before neurological symptoms and are linked to oxidative stress, impacting brain health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ceramide-rich extracellular vesicles as pathogenic biomarkers in traumatic brain injury.

Acta neuropathologica communications·2026
Same author

Trafficking of protein kinases to mitochondria: Implications for ischemic stroke.

Experimental gerontology·2026
Same author

Spatial, temporal and sex specific mitochondrial dynamic changes in severe controlled cortical impact mouse model of traumatic brain injury.

bioRxiv : the preprint server for biology·2026
Same author

Ceramide-rich extracellular vesicles as pathogenic biomarkers in traumatic brain injury.

bioRxiv : the preprint server for biology·2026
Same author

Astrocytic response to traumatic brain injury to rescue neuronal mitochondrial dysfunction through mitochondrial transfer.

bioRxiv : the preprint server for biology·2026
Same author

Tau pathology reprograms glucose metabolism to support cortical hyperexcitability, excitatory/inhibitory imbalance, and sleep loss.

NPJ dementia·2026

Area of Science:

  • Neuroscience
  • Metabolic disorders
  • Mitochondrial biology

Background:

  • Alzheimer's disease (AD) is increasingly linked to disruptions in cellular energy metabolism.
  • Abnormalities in cerebral metabolism may precede the onset of neurological dysfunction and neuropathology in AD.
  • Mitochondria, central to energy production, are implicated in AD pathophysiology.

Purpose of the Study:

  • To explore the role of energy metabolism disruptions in Alzheimer's disease.
  • To investigate the connection between mitochondrial dysfunction and oxidative stress in AD.
  • To understand how metabolic changes contribute to AD pathogenesis.

Main Methods:

  • Review of evidence linking metabolic changes to AD.
  • Analysis of mitochondrial enzyme inhibition in AD.

Related Experiment Videos

  • Examination of oxidative stress markers and mitochondrial damage in AD.

    • Main Results:

    • Cerebral metabolic abnormalities are observed early in Alzheimer's disease.
    • Inhibition of key mitochondrial enzymes (e.g., pyruvate dehydrogenase) is implicated.
    • Mitochondrial dysfunction, driven by oxidative stress, is a significant factor in AD.

    Conclusions:

    • Energy metabolism disruptions are a fundamental aspect of Alzheimer's disease.
    • Mitochondrial dysfunction and oxidative stress are key contributors to AD neuropathology.
    • Targeting metabolic pathways may offer therapeutic strategies for AD.